Kering (ENXTPA:KER) Secured Gucci Beauty Rights, Is The Discount To Fair Value Enough?

L’Oréal’s new fifty-year exclusive license for Gucci fragrances and beauty, effective from July 2027 subject to approvals, places Kering (ENXTPA:KER) at the center of a long-term brand partnership discussion.

See our latest analysis for Kering.

At a share price of €245.8, Kering has a 1 day share price return of 2.57%, while the share price is down 19.30% year to date and the 5 year total shareholder return has declined 62.02%. This suggests longer term momentum has been weak despite a 20.91% total shareholder return over the past year.

If this Gucci beauty agreement has you thinking about where ownership influence really matters in markets, it could be worth broadening your radar with the 108 top founder-led companies

Kering now trades roughly 15% below the average analyst price target after a sharp setback in recent years. Is that discount a signal that the market is too cautious, or is it a fair reflection of Gucci’s current reset?

Most Popular Narrative: 13% Undervalued

Kering’s most followed valuation narrative points to a fair value of about €282 per share, compared with the recent close at €245.8, putting a clear focus on how future cash generation could bridge that gap.

Structural and ongoing cost discipline, with reductions in OpEx and workforce, much of it permanent, should provide sustained improvement to net margins and earnings as fixed costs remain lower even as revenues recover.

Read the complete narrative.

Want to understand why this narrative leans on efficiency as much as growth? It blends margin rebuild, measured revenue assumptions and a valuation multiple that has to do a lot of work.

Result: Fair Value of €282.46 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this Kering narrative could be knocked off course if brand refresh efforts fail to rebuild demand or if ongoing store closures weigh more heavily on future sales capacity.

Find out about the key risks to this Kering narrative.

Another View on Kering’s Valuation

The most followed Kering narrative leans on future earnings and cash flows, but the SWS DCF model paints a cooler picture today. At a share price of €245.8 and an estimated future cash flow value of €237.37, Kering screens as slightly overvalued. Which story should carry more weight for you?

For a closer look at how a cash flow driven lens values Kering over time, it is worth spending a few minutes with the Look into how the SWS DCF model arrives at its fair value.

Next Steps

Feeling torn between the cautious tone around Kering’s reset and the potential upside in its valuation story? Take a closer look at the underlying data, weigh both the concerns and the upside, and then review the 1 key reward and 1 important warning sign

Looking for more investment ideas beyond Kering?

If Kering has sharpened your focus on valuation and quality, it is worth lining up a few other potential ideas so you are not relying on a single story.

• Spot potential upside by scanning 214 high quality undervalued stocks that combine stronger fundamentals with prices that may not fully reflect their underlying businesses.
• Build a steadier income stream by reviewing 470 dividend fortresses that pair higher yields with businesses focused on ongoing shareholder returns.
• Dial down portfolio stress by checking 293 resilient stocks with low risk scores that screen well on financial robustness and overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com